Literature DB >> 206216

Liver resection in children with hepatic neoplasms.

J G Randolph, R P Altman, R M Arensman, M E Matlak, S L Leikin.   

Abstract

In the past ten years, 28 patients with primary tumors of the liver have been treated. There were 11 benign tumors, including four hamartomas, three patients with focal nodular hyperplasia, and two each with congenital cysts and hemangioma. Hamartomas and masses of focal nodular hyperplasia should be excised when possible, but both are benign lesions; therefore life threatening excisions at the porta hepatis should be avoided. Cysts are often resectable, but when occupying all lobes of the liver, they can be successfully managed by marsupialization into the free peritoneal cavity. If resectable, hemangiomas should be removed; when occupying most of the liver as they often do, patients may be subject to platelet trapping or to cardiac failure. In some instances these lesions have been controlled by steroids, radiation therapy or hepatic artery ligation. Of 17 malignant tumors seen, 12 proved to be hepatoblastomas. Nine of the 12 patients underwent liver resection, of whom four are cured, (33%). There were three children with hepatocellular carcinomas and two with embryonal rhabdomyosarcoma. One child from each of these groups is cured by surgical excision. At present the only known cures in children with primary malignant liver neoplasms have been achieved by operative removal.

Entities:  

Mesh:

Year:  1978        PMID: 206216      PMCID: PMC1396458          DOI: 10.1097/00000658-197806000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Technic of hepatic lobectomy.

Authors:  J K QUATTLEBAUM; J K QUATTLEBAUM
Journal:  Ann Surg       Date:  1959-05       Impact factor: 12.969

2.  Haemangioendothelioma of the liver simulating congenital heart disease in an infant.

Authors:  C B LEVICK; J RUBIE
Journal:  Arch Dis Child       Date:  1953-02       Impact factor: 3.791

3.  Primary liver tumors in infancy and childhood. 41 cases variously treated.

Authors:  H W Clatworthy; M Schiller; J L Grosfeld
Journal:  Arch Surg       Date:  1974-08

4.  Malignant liver tumors in children.

Authors:  S H Ein; C A Stephens
Journal:  J Pediatr Surg       Date:  1974-08       Impact factor: 2.545

5.  Hepatic lobectomy in childhood: effectws of x-ray and chemotherapy.

Authors:  R M Filler; M Tefft; F Vawter; C Maddock; A Mitus
Journal:  J Pediatr Surg       Date:  1969-02       Impact factor: 2.545

6.  Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases.

Authors:  K G Ishak; P R Glunz
Journal:  Cancer       Date:  1967-03       Impact factor: 6.860

7.  Alpha fetoprotein in embryonal hepatoblastoma.

Authors:  M E Alpert; R A Seeler
Journal:  J Pediatr       Date:  1970-12       Impact factor: 4.406

8.  Hepatic lobectomy for hepatoblastoma in infants and children.

Authors:  L W Martin; K S Woodman
Journal:  Arch Surg       Date:  1969-01

9.  Angiographic appearnace of benign and malignant hepatic tumors in infants and children.

Authors:  A A Moss; R E Clark; A J Palubinskas; A A DeLorimier
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1971-09

10.  Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood.

Authors:  H A EDMONDSON
Journal:  AMA J Dis Child       Date:  1956-02
View more
  4 in total

1.  Comparison of childhood hepatic malignancies in a hepatitis B hyper-endemic area.

Authors:  Jeng-Chang Chen; Ming-Ling Chang; Jer-Nan Lin; Hong-Shiee Lai; Chiu-Chiang Chen; Wei-Jao Chen; Wen-Tsung Hung
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

2.  Hepatectomy in children.

Authors:  S Iwatsuki; T E Starzl
Journal:  Int Adv Surg Oncol       Date:  1982

3.  Liver lesions and oral contraceptives.

Authors:  A N Freedman
Journal:  Can Med Assoc J       Date:  1982-05-15       Impact factor: 8.262

4.  Malignant liver tumors in infants and children.

Authors:  J Randolph; R Chandra; S Leiken
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.